Experimental vein valve repair device tested in 14 patients, trial halted early

NCT ID NCT03216005

Terminated Disease control Sponsor: Intervene, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device called the BlueLeaf System to fix faulty valves in leg veins of people with chronic venous insufficiency (CVI). The goal was to see if it could safely reduce backward blood flow and improve symptoms. Only 14 people took part before the trial was stopped. The main measures were changes in vein reflux time and risk of blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC VENOUS INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic venous insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC VENOUS INSUFFICIENCY

Contacts and locations

Locations

Auckland City Hospital

Auckland, New Zealand
Clinical Trials New Zealand Ltd

Hamilton, New Zealand
Prince of Wales

Randwick, New South Wales, 2031, Australia
Royal Prince Alfred

Camperdown, New South Wales, 2050, Australia
Vancouver Coastal Health Research Institute

Vancouver, British Columbia, V5Z 1M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.